Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Saag

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2015
Dynamic Visual Display of Treatment Response in HIV-Infected AdultsJessie K Edwards, Stephen R Cole, Jeffrey N Martin, et al.
Addictive Behaviors|June 22, 2013
A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIVKaren L Cropsey, Peter S Hendricks, Bianca Jardin, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 23, 2008
The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of AmericaRita B Effros, Steven Austad, Helen Blau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW ProgramGina M Wingood, Ralph J DiClemente, Isis Mikhail, et al.
AIDS (London, England)|April 7, 2007
Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patientsRichard Haubrich, Dan Berger, Philippe Chiliade, et al.
Lancet (London, England)|July 19, 2011
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialJean-Michel Molina, Pedro Cahn, Beatriz Grinsztejn, et al.
HIV Clinical Trials|August 26, 2010
Efficacy and safety of maraviroc versus efavirenz, both with zidovudine/lamivudine: 96-week results from the MERIT studyJuan Sierra-Madero, Giovanni Di Perri, Robin Wood, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 17, 2011
Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measuresLaura E Gibbons, Betsy J Feldman, Heidi M Crane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2016
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/SofosbuvirCurtis Cooper, Susanna Naggie, Michael Saag, et al.
AIDS (London, England)|July 2, 2014
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findingsDavid A Cooper, Jayvant Heera, Prudence Ive, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2015
Dynamic Visual Display of Treatment Response in HIV-Infected AdultsJessie K Edwards, Stephen R Cole, Jeffrey N Martin, et al.
Addictive Behaviors|June 22, 2013
A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIVKaren L Cropsey, Peter S Hendricks, Bianca Jardin, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 23, 2008
The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of AmericaRita B Effros, Steven Austad, Helen Blau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW ProgramGina M Wingood, Ralph J DiClemente, Isis Mikhail, et al.
AIDS (London, England)|April 7, 2007
Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patientsRichard Haubrich, Dan Berger, Philippe Chiliade, et al.
Lancet (London, England)|July 19, 2011
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialJean-Michel Molina, Pedro Cahn, Beatriz Grinsztejn, et al.
HIV Clinical Trials|August 26, 2010
Efficacy and safety of maraviroc versus efavirenz, both with zidovudine/lamivudine: 96-week results from the MERIT studyJuan Sierra-Madero, Giovanni Di Perri, Robin Wood, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 17, 2011
Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measuresLaura E Gibbons, Betsy J Feldman, Heidi M Crane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2016
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/SofosbuvirCurtis Cooper, Susanna Naggie, Michael Saag, et al.
AIDS (London, England)|July 2, 2014
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findingsDavid A Cooper, Jayvant Heera, Prudence Ive, et al.
Pageof 9